According to Market IntelliX Research, the global market for Eosinophilic Disease should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Eosinophilic Disease market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Eosinophilic Disease market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Corticosteroids segment holds a share about % in 2023 and will reach % in 2030; while in terms of application, Eosinophilic Esophagitis has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Eosinophilic Disease include Takeda Pharmaceutical Company Limited, Ellodi Pharmaceuticals, Bristol-Myers Squibb Company, AstraZeneca, GSK plc, Regeneron Pharmaceuticals Inc, Allakos Inc, Arena Pharmaceuticals Ltd and Revolo Biotherapeutics, etc. In 2023, the global top five players hold a share approximately % in terms of revenue.

Eosinophils are the variety of white infection, allergy blood cells and one of the major immune system components helps in combating various and inflammatory diseases. Eosinophils develops and mature in the bone marrow and represent upto 6% of bone marrow. If the threshold of 1500 cells/μl crosses called as eosinophil-driven diseases, which causes severe inflammatory diseases and organ damage.

This report aims to provide a comprehensive study of the global market for Eosinophilic Disease. Report Highlights:

(1) Global Eosinophilic Disease market size (sales volume & revenue),history data from 2019-2024 and forecast data from 2024 to 2030.

(2) Global Eosinophilic Disease market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(3) China Eosinophilic Disease market competitive situation, sales, revenue, price and market share, from 2019 to 2024.

(4) Global Eosinophilic Disease segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Eosinophilic Disease segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Eosinophilic Disease, capacity, production and trends.

(7) Eosinophilic Disease industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Corticosteroids

Monoclonal Antibodies

Anti-cytokine Drug

Cytotoxic Drug

Market segment by application, can be divided into

Eosinophilic Esophagitis

Eosinophilic Granulomatosis with Polyangiitis

Hyper-eosinophilic Syndrome

Nasal Polyposis

Other

Market segment by players, this report covers

Takeda Pharmaceutical Company Limited

Ellodi Pharmaceuticals

Bristol-Myers Squibb Company

AstraZeneca

GSK plc

Regeneron Pharmaceuticals Inc

Allakos Inc

Arena Pharmaceuticals Ltd

Revolo Biotherapeutics

DBV Technologies

Cipla Inc

Sun Pharmaceutical Industries Ltd

Sanofi

1 Market Overview

1.1 Eosinophilic Disease Definition

1.2 Global Eosinophilic Disease Market Size and Forecast

1.2.1 By Revenue, Global Eosinophilic Disease Market Size, 2019-2030

1.2.2 By Sales Volume, Global Eosinophilic Disease Market Size, 2019-2030

1.2.3 Global Eosinophilic Disease Price Trend, 2019-2030

1.3 China Eosinophilic Disease Market Size and Forecast

1.3.1 By Revenue, China Eosinophilic Disease Market Size, 2019-2030

1.3.2 By Sales Volume, China Eosinophilic Disease Market Size, 2019-2030

1.3.3 China Eosinophilic Disease Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Eosinophilic Disease Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Eosinophilic Disease Share in Global Market, 2019-2030

1.4.3 Eosinophilic Disease Market Size: China VS Global, 2019-2030

1.5 Eosinophilic Disease Market Dynamics

1.5.1 Eosinophilic Disease Market Drivers

1.5.2 Eosinophilic Disease Market Restraints

1.5.3 Eosinophilic Disease Industry Trends

1.5.4 Eosinophilic Disease Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Eosinophilic Disease Revenue by Company, 2019-2024

2.2 Global Eosinophilic Disease Sales Volume by Company, 2019-2024

2.3 Global Eosinophilic Disease Price by Company, 2019-2024

2.4 Global Eosinophilic Disease Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Eosinophilic Disease Concentration Ratio

2.6 Global Eosinophilic Disease Mergers & Acquisitions, Expansion Plans

2.7 Global Eosinophilic Disease Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Eosinophilic Disease Revenue by Company, 2019-2024

3.2 China Eosinophilic Disease Sales Volume by Company, 2019-2024

3.3 China Eosinophilic Disease Eosinophilic Disease Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Eosinophilic Disease Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, Eosinophilic Disease Domestic VS Export

3.6 China Market, Eosinophilic Disease Import & Export

3.6.1 China Market, Eosinophilic Disease Import & Export, 2019-2030

3.6.2 China Eosinophilic Disease Import & Export Trends

3.6.3 Main Sources of China Eosinophilic Disease Import

3.6.4 Export Destination of China Eosinophilic Disease

4 Eosinophilic Disease Production by Region

4.1 Global Eosinophilic Disease Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Eosinophilic Disease Manufacturers

4.3 Global Major Manufacturers, Eosinophilic Disease Capacity Expansion and Future Plans

4.4 Global Eosinophilic Disease Capacity by Region

4.5 Global Eosinophilic Disease Production by Region

4.5.1 Global Eosinophilic Disease Production & Forecast by Region, 2019 VS 2024 VS 2030

4.5.2 Global Eosinophilic Disease Production by Region, 2019-2024

4.5.3 Global Eosinophilic Disease Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Eosinophilic Disease Industry Chain

5.2 Eosinophilic Disease Upstream Analysis

5.2.1 Eosinophilic Disease Core Raw Materials

5.2.2 Main Manufacturers of Eosinophilic Disease Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Eosinophilic Disease Production Mode

5.6 Eosinophilic Disease Procurement Model

5.7 Eosinophilic Disease Industry Sales Model and Sales Channels

5.7.1 Eosinophilic Disease Sales Model

5.7.2 Eosinophilic Disease Typical Distributors

6 Sights by Type

6.1 Eosinophilic Disease Classification

6.1.1 Corticosteroids

6.1.2 Monoclonal Antibodies

6.1.3 Anti-cytokine Drug

6.1.4 Cytotoxic Drug

6.2 By Type, Global Eosinophilic Disease Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global Eosinophilic Disease Revenue, 2019-2030

6.4 By Type, Global Eosinophilic Disease Sales Volume, 2019-2030

6.5 By Type, Global Eosinophilic Disease Price, 2019-2030

7 Sights by Application

7.1 Eosinophilic Disease Segment by Application

7.1.1 Eosinophilic Esophagitis

7.1.2 Eosinophilic Granulomatosis with Polyangiitis

7.1.3 Hyper-eosinophilic Syndrome

7.1.4 Nasal Polyposis

7.1.5 Other

7.2 By Application, Global Eosinophilic Disease Market Size & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global Eosinophilic Disease Revenue, 2019-2030

7.4 By Application, Global Eosinophilic Disease Sales Volume, 2019-2030

7.5 By Application, Global Eosinophilic Disease Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Eosinophilic Disease Market Size, 2019 VS 2024 VS 2030

8.2 By Region, Global Eosinophilic Disease Revenue, 2019-2030

8.3 By Region, Global Eosinophilic Disease Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Eosinophilic Disease Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Eosinophilic Disease Market Size Market Share

8.5 Europe

8.5.1 Europe Eosinophilic Disease Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Eosinophilic Disease Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Eosinophilic Disease Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Eosinophilic Disease Market Size Market Share

8.7 South America

8.7.1 South America Eosinophilic Disease Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Eosinophilic Disease Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Eosinophilic Disease Market Size & CAGR，2019 VS 2024 VS 2030

9.2 By Country, Global Eosinophilic Disease Revenue, 2019-2030

9.3 By Country, Global Eosinophilic Disease Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Eosinophilic Disease Market Size, 2019-2030

9.4.2 By Company, U.S. Eosinophilic Disease Sales Volume Market Share, 2023

9.4.3 By Type, U.S. Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.4.4 By Application, U.S. Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.5 Europe

9.5.1 Europe Eosinophilic Disease Market Size, 2019-2030

9.5.2 By Company, Europe Eosinophilic Disease Sales Volume Market Share, 2023

9.5.3 By Type, Europe Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.5.4 By Application, Europe Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.6 China

9.6.1 China Eosinophilic Disease Market Size, 2019-2030

9.6.2 By Company, China Eosinophilic Disease Sales Volume Market Share, 2023

9.6.3 By Type, China Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.6.4 By Application, China Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.7 Japan

9.7.1 Japan Eosinophilic Disease Market Size, 2019-2030

9.7.2 By Company, Japan Eosinophilic Disease Sales Volume Market Share, 2023

9.7.3 By Type, Japan Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.7.4 By Application, Japan Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.8 South Korea

9.8.1 South Korea Eosinophilic Disease Market Size, 2019-2030

9.8.2 By Company, South Korea Eosinophilic Disease Sales Volume Market Share, 2023

9.8.3 By Type, South Korea Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.8.4 By Application, South Korea Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.9 Southeast Asia

9.9.1 Southeast Asia Eosinophilic Disease Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Eosinophilic Disease Sales Volume Market Share, 2023

9.9.3 By Type, Southeast Asia Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.9.4 By Application, Southeast Asia Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.10 India

9.10.1 India Eosinophilic Disease Market Size, 2019-2030

9.10.2 By Company, India Eosinophilic Disease Sales Volume Market Share, 2023

9.10.3 By Type, India Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.10.4 By Application, India Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.11 Middle East & Asia

9.11.1 Middle East & Asia Eosinophilic Disease Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Eosinophilic Disease Sales Volume Market Share, 2023

9.11.3 By Type, Middle East & Asia Eosinophilic Disease Market Size, Share, 2023 VS 2030

9.11.4 By Application, Middle East & Asia Eosinophilic Disease Market Size, Share, 2023 VS 2030

10 Manufacturers Profile

10.1 Takeda Pharmaceutical Company Limited

10.1.1 Takeda Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position

10.1.2 Takeda Pharmaceutical Company Limited Eosinophilic Disease Models, Specifications and Application

10.1.3 Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Takeda Pharmaceutical Company Limited Company Profile and Main Business

10.1.5 Takeda Pharmaceutical Company Limited Recent Developments

10.2 Ellodi Pharmaceuticals

10.2.1 Ellodi Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

10.2.2 Ellodi Pharmaceuticals Eosinophilic Disease Models, Specifications and Application

10.2.3 Ellodi Pharmaceuticals Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 Ellodi Pharmaceuticals Company Profile and Main Business

10.2.5 Ellodi Pharmaceuticals Recent Developments

10.3 Bristol-Myers Squibb Company

10.3.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

10.3.2 Bristol-Myers Squibb Company Eosinophilic Disease Models, Specifications and Application

10.3.3 Bristol-Myers Squibb Company Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Bristol-Myers Squibb Company Company Profile and Main Business

10.3.5 Bristol-Myers Squibb Company Recent Developments

10.4 AstraZeneca

10.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

10.4.2 AstraZeneca Eosinophilic Disease Models, Specifications and Application

10.4.3 AstraZeneca Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 AstraZeneca Company Profile and Main Business

10.4.5 AstraZeneca Recent Developments

10.5 GSK plc

10.5.1 GSK plc Company Information, Head Office, Market Area and Industry Position

10.5.2 GSK plc Eosinophilic Disease Models, Specifications and Application

10.5.3 GSK plc Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 GSK plc Company Profile and Main Business

10.5.5 GSK plc Recent Developments

10.6 Regeneron Pharmaceuticals Inc

10.6.1 Regeneron Pharmaceuticals Inc Company Information, Head Office, Market Area and Industry Position

10.6.2 Regeneron Pharmaceuticals Inc Eosinophilic Disease Models, Specifications and Application

10.6.3 Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 Regeneron Pharmaceuticals Inc Company Profile and Main Business

10.6.5 Regeneron Pharmaceuticals Inc Recent Developments

10.7 Allakos Inc

10.7.1 Allakos Inc Company Information, Head Office, Market Area and Industry Position

10.7.2 Allakos Inc Eosinophilic Disease Models, Specifications and Application

10.7.3 Allakos Inc Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Allakos Inc Company Profile and Main Business

10.7.5 Allakos Inc Recent Developments

10.8 Arena Pharmaceuticals Ltd

10.8.1 Arena Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position

10.8.2 Arena Pharmaceuticals Ltd Eosinophilic Disease Models, Specifications and Application

10.8.3 Arena Pharmaceuticals Ltd Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 Arena Pharmaceuticals Ltd Company Profile and Main Business

10.8.5 Arena Pharmaceuticals Ltd Recent Developments

10.9 Revolo Biotherapeutics

10.9.1 Revolo Biotherapeutics Company Information, Head Office, Market Area and Industry Position

10.9.2 Revolo Biotherapeutics Eosinophilic Disease Models, Specifications and Application

10.9.3 Revolo Biotherapeutics Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Revolo Biotherapeutics Company Profile and Main Business

10.9.5 Revolo Biotherapeutics Recent Developments

10.10 DBV Technologies

10.10.1 DBV Technologies Company Information, Head Office, Market Area and Industry Position

10.10.2 DBV Technologies Eosinophilic Disease Models, Specifications and Application

10.10.3 DBV Technologies Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.10.4 DBV Technologies Company Profile and Main Business

10.10.5 DBV Technologies Recent Developments

10.11 Cipla Inc

10.11.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position

10.11.2 Cipla Inc Eosinophilic Disease Models, Specifications and Application

10.11.3 Cipla Inc Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.11.4 Cipla Inc Company Profile and Main Business

10.11.5 Cipla Inc Recent Developments

10.12 Sun Pharmaceutical Industries Ltd

10.12.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

10.12.2 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Models, Specifications and Application

10.12.3 Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.12.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business

10.12.5 Sun Pharmaceutical Industries Ltd Recent Developments

10.13 Sanofi

10.13.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.13.2 Sanofi Eosinophilic Disease Models, Specifications and Application

10.13.3 Sanofi Eosinophilic Disease Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.13.4 Sanofi Company Profile and Main Business

10.13.5 Sanofi Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Eosinophilic Disease Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Eosinophilic Disease Market Restraints

Table 3. Eosinophilic Disease Market Trends

Table 4. Eosinophilic Disease Industry Policy

Table 5. Global Eosinophilic Disease Revenue by Company, 2019-2024, US$ million

Table 6. Global Eosinophilic Disease Revenue Market Share by Company, 2019-2024

Table 7. Global Eosinophilic Disease Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Eosinophilic Disease Sales Volume Market Share by Company, 2019-2024

Table 9. Global Eosinophilic Disease Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Eosinophilic Disease Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Eosinophilic Disease Mergers & Acquisitions, Expansion Plans

Table 12. Global Eosinophilic Disease Manufacturers Product Type

Table 13. China Eosinophilic Disease Revenue by Company, 2019-2024, US$ million

Table 14. China Eosinophilic Disease Revenue Market Share by Company, 2019-2024

Table 15. China Eosinophilic Disease Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Eosinophilic Disease Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Eosinophilic Disease Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Eosinophilic Disease Import & Export Trends

Table 19. Main Sources of China Eosinophilic Disease Import

Table 20. Export Destination of China Eosinophilic Disease

Table 21. Global Headquarters and Manufacturing Base of Eosinophilic Disease Manufacturers

Table 22. Global Major Manufacturers, Eosinophilic Disease Capacity Expansion and Future Plans

Table 23. Global Eosinophilic Disease Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Eosinophilic Disease Production by Region, 2019-2024, (K Units)

Table 25. Global Eosinophilic Disease Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Eosinophilic Disease Upstream (Raw Materials)

Table 27. Global Eosinophilic Disease Typical Customers

Table 28. Eosinophilic Disease Typical Distributors

Table 29. By Type, Global Eosinophilic Disease Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Eosinophilic Disease Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Eosinophilic Disease Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Eosinophilic Disease Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Eosinophilic Disease Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Eosinophilic Disease Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Eosinophilic Disease Revenue Market Share, 2019-2030

Table 37. By Country, Global Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Eosinophilic Disease Sales Volume Market Share, 2019-2030

Table 39. Takeda Pharmaceutical Company Limited Company Information, Head Office, Market Area and Industry Position

Table 40. Takeda Pharmaceutical Company Limited Eosinophilic Disease Models, Specifications and Application

Table 41. Takeda Pharmaceutical Company Limited Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Takeda Pharmaceutical Company Limited Company Profile and Main Business

Table 43. Takeda Pharmaceutical Company Limited Recent Developments

Table 44. Ellodi Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 45. Ellodi Pharmaceuticals Eosinophilic Disease Models, Specifications and Application

Table 46. Ellodi Pharmaceuticals Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Ellodi Pharmaceuticals Company Profile and Main Business

Table 48. Ellodi Pharmaceuticals Recent Developments

Table 49. Bristol-Myers Squibb Company Company Information, Head Office, Market Area and Industry Position

Table 50. Bristol-Myers Squibb Company Eosinophilic Disease Models, Specifications and Application

Table 51. Bristol-Myers Squibb Company Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Bristol-Myers Squibb Company Company Profile and Main Business

Table 53. Bristol-Myers Squibb Company Recent Developments

Table 54. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 55. AstraZeneca Eosinophilic Disease Models, Specifications and Application

Table 56. AstraZeneca Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. AstraZeneca Company Profile and Main Business

Table 58. AstraZeneca Recent Developments

Table 59. GSK plc Company Information, Head Office, Market Area and Industry Position

Table 60. GSK plc Eosinophilic Disease Models, Specifications and Application

Table 61. GSK plc Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. GSK plc Company Profile and Main Business

Table 63. GSK plc Recent Developments

Table 64. Regeneron Pharmaceuticals Inc Company Information, Head Office, Market Area and Industry Position

Table 65. Regeneron Pharmaceuticals Inc Eosinophilic Disease Models, Specifications and Application

Table 66. Regeneron Pharmaceuticals Inc Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Regeneron Pharmaceuticals Inc Company Profile and Main Business

Table 68. Regeneron Pharmaceuticals Inc Recent Developments

Table 69. Allakos Inc Company Information, Head Office, Market Area and Industry Position

Table 70. Allakos Inc Eosinophilic Disease Models, Specifications and Application

Table 71. Allakos Inc Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Allakos Inc Company Profile and Main Business

Table 73. Allakos Inc Recent Developments

Table 74. Arena Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position

Table 75. Arena Pharmaceuticals Ltd Eosinophilic Disease Models, Specifications and Application

Table 76. Arena Pharmaceuticals Ltd Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Arena Pharmaceuticals Ltd Company Profile and Main Business

Table 78. Arena Pharmaceuticals Ltd Recent Developments

Table 79. Revolo Biotherapeutics Company Information, Head Office, Market Area and Industry Position

Table 80. Revolo Biotherapeutics Eosinophilic Disease Models, Specifications and Application

Table 81. Revolo Biotherapeutics Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Revolo Biotherapeutics Company Profile and Main Business

Table 83. Revolo Biotherapeutics Recent Developments

Table 84. DBV Technologies Company Information, Head Office, Market Area and Industry Position

Table 85. DBV Technologies Eosinophilic Disease Models, Specifications and Application

Table 86. DBV Technologies Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. DBV Technologies Company Profile and Main Business

Table 88. DBV Technologies Recent Developments

Table 89. Cipla Inc Company Information, Head Office, Market Area and Industry Position

Table 90. Cipla Inc Eosinophilic Disease Models, Specifications and Application

Table 91. Cipla Inc Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Cipla Inc Company Profile and Main Business

Table 93. Cipla Inc Recent Developments

Table 94. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 95. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Models, Specifications and Application

Table 96. Sun Pharmaceutical Industries Ltd Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Sun Pharmaceutical Industries Ltd Company Profile and Main Business

Table 98. Sun Pharmaceutical Industries Ltd Recent Developments

Table 99. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 100. Sanofi Eosinophilic Disease Models, Specifications and Application

Table 101. Sanofi Eosinophilic Disease Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Sanofi Company Profile and Main Business

Table 103. Sanofi Recent Developments

List of Figure

Figure 1. Eosinophilic Disease Picture

Figure 2. By Revenue, Global Eosinophilic Disease Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Eosinophilic Disease Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Eosinophilic Disease Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Eosinophilic Disease Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Eosinophilic Disease Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Eosinophilic Disease Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Eosinophilic Disease Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Eosinophilic Disease Share of Global Market, 2019-2030

Figure 10. Global Eosinophilic Disease Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Eosinophilic Disease Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Eosinophilic Disease Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Eosinophilic Disease Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Eosinophilic Disease Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Eosinophilic Disease Domestic VS Export, 2022

Figure 16. Global Eosinophilic Disease Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Eosinophilic Disease Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Eosinophilic Disease Production Market Share & Forecast by Region, 2019-2030

Figure 19. Eosinophilic Disease Industry Chain

Figure 20. Eosinophilic Disease Procurement Model

Figure 21. Eosinophilic Disease Sales Model

Figure 22. Eosinophilic Disease Sales Channels, Direct Sales and Distribution

Figure 23. Corticosteroids

Figure 24. Monoclonal Antibodies

Figure 25. Anti-cytokine Drug

Figure 26. Cytotoxic Drug

Figure 27. By Type, Global Eosinophilic Disease Revenue, 2019-2030, US$ Million

Figure 28. By Type, Global Eosinophilic Disease Revenue Market Share, 2019-2030

Figure 29. By Type, Global Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 30. By Type, Global Eosinophilic Disease Sales Volume Market Share, 2019-2030

Figure 31. By Type, Global Eosinophilic Disease Price, 2019-2030, (US$/Unit)

Figure 32. Eosinophilic Esophagitis

Figure 33. Eosinophilic Granulomatosis with Polyangiitis

Figure 34. Hyper-eosinophilic Syndrome

Figure 35. Nasal Polyposis

Figure 36. Other

Figure 37. By Application, Global Eosinophilic Disease Revenue, 2019-2030, US$ Million

Figure 38. By Application, Global Eosinophilic Disease Revenue Market Share, 2019-2030

Figure 39. By Application, Global Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 40. By Application, Global Eosinophilic Disease Sales Volume Market Share, 2019-2030

Figure 41. By Application, Global Eosinophilic Disease Price, 2019-2030, (US$/Unit)

Figure 42. By Region, Global Eosinophilic Disease Revenue Market Share, 2019-2030

Figure 43. By Region, Global Eosinophilic Disease Sales Volume Market Share, 2019-2030

Figure 44. North America Eosinophilic Disease Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country, North America Eosinophilic Disease Revenue Market Share, 2022

Figure 46. Europe Eosinophilic Disease Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, Europe Eosinophilic Disease Revenue Market Share, 2022

Figure 48. Asia Pacific Eosinophilic Disease Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. By Country/Region, Asia Pacific Eosinophilic Disease Revenue Market Share, 2022

Figure 50. South America Eosinophilic Disease Revenue & Forecasts, 2019-2030, US$ Million

Figure 51. By Country, South America Eosinophilic Disease Revenue Market Share, 2022

Figure 52. Middle East & Africa Eosinophilic Disease Revenue & Forecasts, 2019-2030, US$ Million

Figure 53. U.S. Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, U.S. Eosinophilic Disease Market Share, 2022

Figure 55. By Type, U.S. Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, U.S. Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 57. Europe Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, Europe Eosinophilic Disease Market Share, 2022

Figure 59. By Type, Europe Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, Europe Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 61. China Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, China Eosinophilic Disease Market Share, 2022

Figure 63. By Type, China Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, China Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 65. Japan Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, Japan Eosinophilic Disease Market Share, 2022

Figure 67. By Type, Japan Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, Japan Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 69. South Korea Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, South Korea Eosinophilic Disease Market Share, 2022

Figure 71. By Type, South Korea Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, South Korea Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 73. Southeast Asia Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, Southeast Asia Eosinophilic Disease Market Share, 2022

Figure 75. By Type, Southeast Asia Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, Southeast Asia Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 77. India Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, India Eosinophilic Disease Market Share, 2022

Figure 79. By Type, India Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application, India Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 81. Middle East & Asia Eosinophilic Disease Sales Volume, 2019-2030, (K Units)

Figure 82. By Company, Middle East & Asia Eosinophilic Disease Market Share, 2022

Figure 83. By Type, Middle East & Asia Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 84. By Application, Middle East & Asia Eosinophilic Disease Sales Volume Market Share, 2022 VS 2029

Figure 85. Research Methodology

Figure 86. Breakdown of Primary Interviews

Figure 87. Bottom-up Approaches

Figure 88. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)